A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Genentech, Inc.1,846 enrolled

Overview

This was a multicenter, prospective, 5-year surveillance study of approximately 5000 Raptiva-treated patients and approximately 500 non-Raptiva treated patients (formerly 2500 comparison patients who were treated with a biologic therapy other than Raptiva) with chronic moderate to severe plaque psoriasis who were candidates for treatment with Raptiva.

Study Type

OBSERVATIONAL

Enrollment

1,846

Conditions

Psoriasis

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Have ever had a physician's diagnosis of chronic moderate to severe plaque psoriasis and be a candidate for treatment with Raptiva * Are being treated with or initiating Raptiva therapy at the time of enrollment * Be able to provide written informed consent * Be willing and able to fully to participate for the duration of patient follow-up (5 years) Exclusion Criterion: * Have previously received at least one dose of Raptiva and are not currently using or restarting treatment with Raptiva at the time of enrollment

Locations (182)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Total Skin and Beauty Dermatology Center

Birmingham, Alabama, United States

Deep South Dermatology

Daphne, Alabama, United States

The Dermatology Center

Gadsden, Alabama, United States

Medical Affiliated Research Center, Inc.

Huntsville, Alabama, United States

Ruth A. Yates, MD

Huntsville, Alabama, United States

SunValley Arthritis Center Ltd

Glendale, Arizona, United States

Alliance Dermatology and MOHS

Phoenix, Arizona, United States

BGPDS Dermatology

Little Rock, Arkansas, United States

Hull Dermatology, PA

Rogers, Arkansas, United States

Bakersfield Dermatology and Skin Cancer Medical Grp

Bakersfield, California, United States

...and 172 more locations